Anastrozole Tablet, Film Coated
Product Images NDC 0093-7536

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 0093-7536). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Anastrozole Tablets Usp A078058 1

FDA Label Image

Anastrozole Tablets Usp A078058 2

FDA Label Image

Anastrozole Tablets Usp A078058 3

FDA Label Image

Anastrozole Tablets Usp A078058 4

FDA Label Image

Anastrozole Tablets Usp A078058 5

FDA Label Image

Anastrozole Tablets Usp A078058 6

FDA Label Image

Anastrozole Tablets Usp A078058 7

FDA Label Image

Anastrozole Tablets Usp A078058 8

Anastrozole Tablets Usp A078058 8
This is a label for Anastrozole Tablets, USP manufactured by Teva Pharmaceuticals in Israel and distributed in the USA. The label includes information about the product, manufacturer, distributor, and dosage instructions for pharmacists. The text may be incomplete and difficult to read, due to image distortion or noise.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.